APA (7th ed.) Citation

S, H., S, K., R, G., KD, F., H, K., MT, T., . . . IA, A. (2024). Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling. Stroke, 55(1), 31. https://doi.org/10.1161/STROKEAHA.123.044083

Chicago Style (17th ed.) Citation

S, Hage, et al. "Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling." Stroke 55, no. 1 (2024): 31. https://doi.org/10.1161/STROKEAHA.123.044083.

MLA (9th ed.) Citation

S, Hage, et al. "Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling." Stroke, vol. 55, no. 1, 2024, p. 31, https://doi.org/10.1161/STROKEAHA.123.044083.